#buys #bullish #WallStreet #analysts

$CRSP $NEO $TMUS $TSCO

These are all Buys if you can manage the risk.

Daily HeffX-LTN reviews dozens of Wall Street’s Key analysts research reports to ID new trading and investing ideas for HeffX-LTN readers. These reports cover stocks to buy

Below is our list for Thursday, 30 July, as follows:

CRISPR Therapeutics A.G. (NASDAQ:CRSP): Chardan reiterated its Buy, and raised its target price to 100 from 72.50, and Needham reiterated its Buy rating and raised its target to 105 from 84.

NeoGenomics Inc. (NASDAQ:NEO) was reiterated as Buy and its price target was raised to 39 from 33 at Needham.

T-Mobile US Inc. (NASDAQ:TMUS) was started as Buy with a 140 target price at Deutsche Bank.

Tractor Supply Co. (NASDAQ:TSCO): This rural retailer just had its best Quarter in its history. Shares closed Wednesday at 145.46 and have a consensus price target at 154.18.

Have a healthy day, Keep the Faith!

The following two tabs change content below.

Paul A. Ebeling, a polymath, excels, in diverse fields of knowledge. Pattern Recognition Analysis in Equities, Commodities and Foreign Exchange, and he it the author of "The Red Roadmaster's Technical Report on the US Major Market Indices, a highly regarded, weekly financial market commentary. He is a philosopher, issuing insights on a wide range of subjects to over a million cohorts. An international audience of opinion makers, business leaders, and global organizations recognize Ebeling as an expert.   





Source link